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BRMS1 was ﬁrst discovered as a human breast carcinoma metastasis suppressor gene. However, the
mechanism of BRMS1 in tumor metastasis and its developmental role remain unclear. In this paper, we
ﬁrst report the identiﬁcation of the Drosophila ortholog of human BRMS1, dBrms1. Through a genetic
approach, the role of dBrms1 during development has been investigated. We found that dBrms1 is
an essential gene and loss of dBrms1 function results in lethality at early developmental stages.
dBrms1mutants displayed phenotypes such as developmental delay and failure to initiate metamorpho-
sis. Further analysis suggests that these phenotypes are contributed by defective ecdysone signaling and
expression of target genes of the ecdysone pathway. Therefore, dBrms1 is required for growth control by
acting as a modulator of ecdysone signaling in Drosophila and is required for metamorphosis for normal
development.
& 2013 Elsevier Inc. All rights reserved.Introduction
Human breast cancer metastasis suppressor, hBRMS1, is a tumor
metastasis suppressor gene identiﬁed by differential display
reverse transcriptase-polymerase chain reaction (DD-RT-PCR)
(Seraj et al., 2000). Expression of BRMS1 was found to decrease
the metastatic potential of human breast carcinoma (Seraj et al.,
2000), melanoma (Shevde et al., 2002), and ovarian carcinoma
cell lines (Zhang et al., 2006), but the mechanism of BRMS1 in
suppressing metastasis has not been fully understood. Through
yeast two-hybrid and co-immunoprecipitation studies, BRMS1 is
found to interact with retinoblastoma binding protein 1(RBP1) and
mammalian Sin3-histone deacetylase complex (mSin3-HDAC com-
plex) to function as a transcription co-repressor (Meehan et al.,
2004). Other studies show that BRMS1 down-regulates genes
expression through affecting NF-κB activity (Cicek et al., 2005;
Liu et al., 2006; Samant et al., 2007). It is not clear whether BRMS1
plays any developmental role in regulating tissue and organ
formation.ll rights reserved.
Department of Biochemistry
sity, University Park, PA, USA.Ecdysone and ecdysone receptors (EcR) play an essential role in
Drosophila developmental timing. Pulses of the steroid hormone
ecdysone directly cause developmental transition in ﬂy life cycle,
including molting and metamorphosis (Riddiford, 1993; Thummel,
2001). In response to the pulses of ecdysone, EcR forms a hetero-
dimer with the ultraspiracle protein to induce downstream genes
transcription in a ligand-dependent manner (Koelle et al., 1991;
Thomas et al., 1993; Yao et al., 1992). At the late third-instar larval
stage and all of the metamorphosis stage, Ecdysone receptor induces
different downstream genes, such as Broad-Complex (BR-C), E74, E75,
DHR4 and βFTZ-F1 in a stage- and tissue-speciﬁc manner. Some of the
regulated genes act as transcription factors which regulate expression
of a large set of effector genes. This transcriptional cascade triggers
widespread changes throughout the body (Thummel, 1996, 2001).
Beside 20-hydroxyecdysone (20E), the active form of ecdysone, the
transcriptional activation of ecdysone receptor is also modulated by
co-regulators, such as histone methyltransferases TRR (Sedkov et al.,
2003), dSet2 (Stabell et al., 2007), and dG9a (Stabell et al., 2006),
nucleosome remodeling factor NURF (Badenhorst et al., 2005), and
co-activator taiman (Bai et al., 2000). Among them, mutations of
NURF, dSet2, and dG9a lead to abnormal metamorphosis. It was not
clear whether dBrms1might be involved in modulating ecdysone/EcR
signaling activity.
BRMS1 is evolutionarily conserved in vertebrate and inverte-
brate animals. To gain insight into the developmental role of
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ortholog of BRMS1, during development. We found that loss-of-
function mutation in dBrms1 leads to developmental delay and
defective metamorphosis. This effect could be caused by deceased
expression of ecdysone receptor and its downstream target genes at
the beginning of metamorphosis. Our studies indicate that dBrms1
acts as a modulator of ecdysone signaling in Drosophila development
and is required for metamorphosis.Materials and methods
Drosophila strainsw1118; P{GT1}CG4400BG01329
Sp/Cyo; Δ2–3/TM6B
Df(1)JA27/FM7c, Kr-Gal4, UAS-GFPS65T
tubP-GAL4/TM3
w1118; Sgs3-GFP
w1118; PT- dBrms1-Gal4 (this study)
UAS-GFP-nls
CaSpeR4-dBrms1/CyO (this study)
w1118; UAS-dBrms1/FM7a (this study)
w1118; UAS-EcR-RNAiAll strains were maintained at 25 1C on standard cornmeal
medium.
Data sources
The Accession numbers of the sequences used are BRMS1:
NP_056214 (human), NP_598916 (mouse), NP_956391 (zebraﬁsh).
BRMS1L: NP_115728 (human), AAV83797 (p40, human), NP_
001032845 (mouse), NP_001025273 (zebraﬁsh), NP_572840
(dBrms1, ﬂy). SDS3: NP_071936 (human), NP_848737 (mouse),
NP_001003493 (zebraﬁsh), NP_608325 (CG14220, ﬂy), NP_012182
(yeast). Amino acid sequences were aligned using ClustalX v.1.83,
the tree was constructed by MEGA v4 with the neighbor joining
method.
P-element excision and mutant collection
dBrms1 deletion mutants were generated by P-element im-
precise excision. Brieﬂy, the P-element insertion stain P{GT1}
CG4400BG01329 was ﬁrst crossed to Δ2-3 stain, which expresses
stable P transposase. Detailed protocol for the P-element excision
experiment is available upon request. dBrms1 deletions were
determined by genomic PCR ampliﬁcation of the original
P-element insertion site from P-element jump-out stains. Three
strains (dBrms1050-2, dBrms1074-4, and dBrms1086-2) with dBrms1
deletion were isolated and the exact deletion positions were
conﬁrmed by sequencing analysis. All dBrms1 deletion strains
were maintained by the FM7c, Kr-GAL4, UAS-GFPS65T balancer.
For phenotypic analysis, dBrms1 mutants balanced with FM7c,
Kr-Gal4, UAS-GFPS65T were collected after eclosion and cultured on
standard mediumwith yeast for three days, then eggs were laid on
the apple juice agar plate and collected in 3 h period at 25 1C. The
hatched ﬁrst-instar larvae were identiﬁed as hemizygous mutants
according to the absence of GFP in Bolvic's organs (Casso et al.,
2000). The developmental stages of mutant larvae were deter-
mined by the appearances of mouth hooks and anterior spiracles.
Construction of Drosophila transgenic lines
For genomic rescue, an XbaI/NotI fragment of 3677 bp dBrms1
genomic region was ampliﬁed from w1118 ﬂies by PCR and clonedinto the pCaSpeR4 vector (Thummel and Pirrotta, 1992). The
primers aredBrms1-Grescue-F: CGATCTAGAACCGGCACTTATGTCCAG
dBrms1-Grescue-R: ATCGCGGCCGCGAATATGAGCGAGATGGFor cDNA rescue, a full-length cDNA fragment of dBrms1 was
ampliﬁed by PCR from cDNA clone LD14895 obtained from
the Drosophila Genomics Resource Center (DGRC) and cloned into
the NotI/KpnI sites of pUAST vector (Brand and Perrimon, 1993).
The primers are
dBrms1-cDNArescue-F: TCAGCGGCCGCAAAATCCACTCTGAAAT
dBrms1-cDNArescue-R: TGAGGTACCATAAACGTCTACGGCTGCT
For dBrms1-Gal4 construction, a dBrms1 upstream 764 bp pro-
moter region was used to drive Gal4 expression in the pPT-Gal4
vector (with XbaI/EcoRI cloning sites). The primers are:
dBrms1-promoter-F: GCTCTAGATTAGATTTCGGCTCGACTAGATTG
dBrms1-promoter-R: CGGAATTCTTCAGAGTGGATTTTGCGGT
All vectors constructed with PCR fragments were conﬁrmed by
sequencing. Transgenic ﬂies were generated according to standard
protocols. dBrms1050-2/Y; P[dBrms1-3677]/+ and P[UAS-dBrms1],
dBrms1050-2/Y; tubP-Gal4/+ were established by genetic crosses
and examined for their viability and morphology.
RNA extraction and cDNA preparation
For detection of expression pattern of dBrms1 during develop-
ment, total RNAwas extracted from wild-type embryos to adults at
various stages with Trizol reagent (Invitrogen, Carlsbad, CA).
Reverse transcription was carried out with random primer by
using M-MLV reverse transcriptase (Promega, Madison, WI).
For detection of expression level of ecdysone receptor down-
stream genes, dBrms1+/− and dBrms1−/− larva (5 days after eggs
laying cultured at 25 1C) were collected respectively. Since
dBrms1−/− could not develop to adult stage, the mutants were
maintained in the form of dBrms−/FM7c, Kr-Gal4, UAS-GFPS65T. Eggs
laying in 3 h were collected, and after cultured at 25 1C for about
20 h, dBrms1−/− were identiﬁed by no expression of GFP driven by
Kruppel(Kr) promoter under ﬂuorescent microscopy. Embryos
with GFP expression (dBrms1+/+ and dBrms1+/−) and embryos
without GFP expression (dBrms1−/−) were cultured in different
vials for 5 days, then total RNA were extracted with Trizol reagent.
Reverse transcription was carried out with random nonamer by
using M-MLV reverse transcriptase (Promega, Madison, WI).RT-PCR and qRT-PCR
For detection of expression pattern of dBrms1 during develop-
ment, two rounds of PCR were performed. Primers used for
detection of dBrms1 were
dBrms1-F: GCGAAGGCGACGTTTCTG
dBrms1-R: CGTGTGGCTGGCTGGAAT
gapdh2 (glyceraldehyde-3-phosphate dehydrogenase 2) was
used as an internal control. The gapdh2 primers were
gapdh2F: TGCTCCCATGTTCGTTTGC
gapdh2R: CACCTTCATGTCGGGCTTGT
For detection of expression level of ecdysone receptor down-
stream genes, SYBR Green I-based method and an Applied Biosys-
tems Model 7500 sequence detection system (TaqMan) were used
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cycle) was deﬁned as the cycle number at which the ﬂuorescence
density passed the ﬁxed threshold. To compare the relative mRNA
level, gapdh2 level was used to normalize RNA concentration of
each sample. Each sample was repeated three times. The relative
fold change was calculated based on: fold change [sample (GFP−)/
sample (GFP+)]¼2(CT(GFP−)ww−CT(GFP−)gapdh2)−(CT(GFP+)ww−CT(GFP+)gapdh2).
The primer sequences to detect expression of ecdysone recep-
tor downstream genes are:EcRF: CCGCAAACTGCCCAAGTT
EcRR: GGCGGGATGGCATGAA
UspF: GTGCCAAGTGGTCAACAAACA
UspR: GCATCATGCGCGCGTAT
Eig71EaF: TGGCGCTGGAGGAACGT
Eig71EaR: GCCAACCCAAGCAATTTAGC
Eig71EeF: AGAAAGCGTTGGGTCTCCAA
Eig71EeR: TGAGGCTCCCTGTGTTCGTT
Eip74EFF: CCGGGAAACCCCCAAAC
Eip74EFR: GCTGTCGGTGCGTTGAAGTA
Eip75BF: GATCGCCCCGGTTTGC
Eip75BR: CCTTGAGTCGCGAGTACATCTTC
Eip93FF: AGTATCTGCAGCCGCAATCA
Eip93FR: TCCACACTGGGACTGGGTGTA
Fbp1F: TGAGCGCCGACGTGACT
Fbp1R: TCCATTCTCCAGCTGCACTTG
ImpE2F: GTGCCTGCCGAGGAACTTT
ImpE2R: CCTGGTTTTCCGACTGCTCTT
Sgs1F: GGCCCTGGCAACCTAACC
Sgs1R: TTGGATATCCGGGCATCTGT
Sgs3F: GGATGCACTGTGCCAGGAT
Sgs3R: CGGATCTTGCGCTCCAGATResults
dBrms1 is a Drosophila ortholog of the human BRMS1 gene
Through searching the Drosophila genome database by BLASTP,
the CG4400 gene was found to be homologous to human BRMS1
and BRMS1-like genes (Nikolaev et al., 2004). CG4400 encodes a
259-amino acids protein that shares 43% identity and 65%
similarity with hBRMS1, 40% identity and 66% similarity with
BRMS1L, and 39% identity and 66% similarity with p40. Phylo-
genetic analysis indicates that CG4400 is indeed an ortholog of
mammalian BRMS1 genes, and consequently, we renamed it
dBrms1 (Fig. S1). Interestingly, the Drosophila genome contains
another family member, CG14220, which is an ortholog of mam-
malian suppressor of defective silencing 3 (mSds3) (Alland et al.,
2002) (Fig. S1).dBrms1 mRNA is maternally stored and expressed
throughout development
Through RT-PCR for dBrms1 expression analysis during devel-
opment, dBrms1 was found to be expressed at all developmental
stages, with slightly higher levels of expression in developing
embryos (Fig. 1A). It suggests that dBrms1 is a critical gene and
plays a general role throughout development. To further investi-
gate dBrms1 expression in developing tissues, dBrms1-Gal4 trans-
genic lines were generated so that expression of transcription
factor Gal4 is driven by dBrms1 regulatory sequences. Using UAS-
GFP-nls as a reporter, the dBrms1 promoter was found to be
ubiquitously active in developing tissues. Interestingly, high level
of dBrms1 promoter activity was detected in the ring gland ofthird-instar larvae (Fig. 1B, pointed by the arrow) (Harvie et al.,
1998).Generation of dBrms1 loss-of-function mutations
One P-element insertion strain BG01329 has a P{GT1} element
inserted into the X-chromosome (Bellen et al., 2004), 137 bp
upstream of dBrms1 start code. Both viability and fertility of this
strain were normal. To test whether dBrms1 expression is dis-
rupted by this P-element insertion, we performed RT-PCR and
found that the expression of dBrms1 at the mRNA level had no
difference between wild type and BG01329 ﬂies (Fig. 1C). This
result indicates that dBrms1 should be still functional in this strain.
To explore the function of dBrms1 through a genetic approach,
loss-of-function mutations of dBrms1 were generated by imprecise
excision of BG01329. From a total of 120 excision lines, three stains,
dBrms1050-2, dBrms1074-4, and dBrms1086-2, with dBrms1 coding
sequence deletion had been generated. Among them, dBrms1050-2
is a null allele because 1211 bp DNA sequence including the
entire coding region has been deleted (Fig. 1D). dBrms1074-4 and
dBrms1086-2lost 863bp and 853bp DNA sequence, respectively, that
include both the ﬁrst and second exons (Fig. 1D).dBrms1 mutants are developmentally delayed and die in early stages
The dBrms1 heterozygous mutants developed normally, but no
dBrms1 hemizygotes survived to adult. In order to further char-
acterize the phenotype of dBrms1 mutant, we separated the
hemizygotes from heterozygotes using the ﬁrst balancer chromo-
some with GFP marker at the onset of the ﬁrst-instar larval stage
(see Materials and Methods). The size and morphology of devel-
oping organs were ﬁrst examined. Compared to wild-type organs
like eye-antennal and wing imaginal discs at 5.5-day late third-
instar AED (after egg deposition) stage (Fig. 2A and C), the mutant
eye-antennal and wing discs from dBrms1 hemizygotes were still
smaller even 9-day AED (Fig. 2B and D). Similar observations were
made for other organs such as the brain and salivary gland (data
not shown). Externally, the hemizygotes also showed develop-
mental delay throughout all stages compared with the hetero-
zygotes. For instance, at 5.5-day AED stage (Fig. 2E), dBrms1
hemizygotes were obviously smaller (Fig. 2F), compared to wild-
type (Fig. 2E). Seven-day AED, dBrms1 hemizygotes appeared
morphologically like mature third-instar larvae, but they were
still smaller in size than the control (Fig. 2G). By 9-day AED,
dBrms1 hemizygotes began to wonder away from food, and by
12-day AED, some dBrms1 mutants became prepupae but still
cannot complete the transition from prepupae to the pupal stage
(Fig. 2H). This was supported by the facts that dBrms1 hemizygotes
failed to shorten the body completely, evert spiracles, and harden
their cuticle. The mutants died at this stage. In contrary, normal
larvae entered the pupal stage by the end of 5-day AED. Around
10–11 day AED, they completed the pupal stage and eclosed to
become adults. Thus, loss of dBrms1 function causes severe delay
of tissue, organ and body development.
Developmental stages at which dBrms1 mutants die have been
determined. 30–40% of the hemizygotes died at the ﬁrst- and
second-instar larval stages and the rest survived to the third-instar
larval stage (Fig. 2I). The hemizygotes stayed at the third-instar
larvae stage for more than 10 days and most of the survivors
(about 50% of the total mutants) eventually died in larval state,
with a small fraction of them (10–20% of the total mutants) died in
prepupal state (Fig. 2I). Therefore, dBrms1 is essential for the
viability of developing ﬂies.
Embryo Larva Pupa Adult
dBrms1
Gapdh2
1000 bp P{GT1}
dBrms1
Gapdh2
WT BG01329
1211bp
863 bp
853 bp
050-2
074-4
086-2
dBrms1
3677 bp
Genomic rescue region
Fig. 1. Expression analysis of the dBrms1 gene and genomic map of dBrms1 mutants. (A). dBrms1 mRNA is maternally stored and expressed throughout development. RT-PCR
detection of dbrms1mRNA expression at several developmental stages, gapdh2 was used as a control. L3e: early third-instar larval stage; L3l: late third-instar larval stage; Pe:
early pupal stage; Pm: mid pupal stage; F: female; M: male; and h: hour after egg deposition. (B). A confocal imaging of w1118; dBrms1-Gal4/+; UAS-GFP-nls/+ at the third-
instar larval stage. The arrow indicates the ring gland. The upper scale bar is 100 um. (C). The mRNA expression of dbrms1 in wild-type (the left lane) and P element insertion
strain BG01329 (the right lane) was analyzed by RT-PCR. (D). The genomic region that includes dBrms1 and its neighboring genes is outlined on the top. The P-element
BG01329 inserted in the 5′ untranslated region of dBrms1 is illustrated by a triangle. Arrows indicate the direction of gene transcription. Structures of three dBrms1 mutants
are illustrated with their corresponding deletion regions (1211 bp, 863 bp and 853 bp respectively for 050-2, 074-4 and 086-2 mutant alleles). A 3677 bp genomic region of
dBrms1 for mutant rescue is depicted at the bottom. The genomic map was drawn by Gene Palette (Rebeiz and Posakony, 2004).
Fig. 2. Phenotypical analysis of loss of dBrms1 function mutants. (A–D). Bright-ﬁeld images of 5.5-day AED dBrms1 heterozygous third-instar larval eye (A) and wing
(C) imaginal discs are depicted to show their normal morphology and size. Loss of dBrms1 function severely delayed the development of organs such as the eye (B) and wing
(D), which were derived from 9-day AED larvae. The mutant organs are much smaller in size. (E). A 5.5-day AED dBrms1 heterozygous late third-instar larva is shown as a
normal control. (F–H). dBrmas1 mutant larvae or pupae are depicted: 5.5-day AED laeva (F), 7-day AED larva (G), and 12-day AED pre-pupa (H). Development of dBrms1
mutants was clearly delayed. (I). Percentages of dBrms1 mutants that died at different developmental stages. L1: ﬁrst-instar larval stage; L2: the second-instar larval stage;
L3: the third-instar larval stage. N: the number of animals that have been analyzed.
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In order to ensure that the phenotypes are caused by dBrms1
mutation, real-time RT-PCR was used to examine the expression
of dBrms1 in hemizygotes dBrms1050-2, the results showed that
no dBrms1 mRNA was detected in dBrms1050-2 stains (Fig. 3A).
Therefore, dBrms1050-2 is indeed a null allele.
To test the ability of dBrms1 to rescue the mutant phenotypes, a
3677-bp genomic DNA that includes the entire dBrms1 gene was
used to generate transgenic ﬂies (Fig. 1D). For all four transgenic
lines with the genomic dBrms1 transgene inserted on the second
chromosome, lethality of dBrms1050-2/Y was completely rescued as
dBrms1050-2/Y; P[dBrms1-3677]/+ ﬂies developed normally to the
adult stage without any obvious morphological defects. Similarly, a
dBrms1 full-length cDNA under the control of UAS and tubulin-Gal41
1.2
1.4
0.6
0.8
GFP+
0.2
0.4
GFP-
0
Fig. 3. Loss of dBrms1 function reduced expression of many target genes of the ecdyson
major target genes of the ecdysone pathway in dBrms1 heterozygotes (GFP+, white ba
heterozygote and hemizygotes was monitored through direct observation of GFP ﬂuore
Fig. 4. Genetic interaction between dBrms1 and EcR. (A–D). Images of adult eyes are dis
(D) defects caused by loss of EcR function in the eye. (E). dBrms1 mutation dominantly
number of ﬂies used for statistical analysis.was also capable to rescue all the defects of dBrms1050-2 mutants,
including lethality and developmental delay phenotypes. There-
fore, developmental defects observed in the mutants are due to
the deﬁcit of dBrms1 function.
Expressions of many EcR target genes in dBrms1 mutants are reduced
The developmental delay phenotype and inability to start
metamorphosis of dBrms1 mutants suggest that the mutants
may fail to respond to ecdysone signaling or ecdysone biosynthesis
is blocked. At the onset of metamorphosis, a set of genes which
are activated by ecdysone receptor, the heterodimer of EcR and
Ultraspiracle (USP), respond to the pulse of ecdysone (Andres
et al., 1993). Primary response genes such as the transcription
activator Broad-Complex (BR-C), E74, and E75, others encoding nonSgs3-GFP
dBrms1-/+ dBrms1-
e signaling pathway. (A). qRT-PCR was carried out to determine expression levels of
rs) and hemizygotes (GFP-, gray bars). (B). The expression of Sgs3-GFP in dBrms1
scence.
played. Wild-type (A); Representative eyes with slight (B), moderate (C) and severe
enhanced the defective eye phenotype caused by loss of EcR function. n: the total
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transcriptionally activated by EcR/USP heterodimer in a ligand-
dependent manner (Koelle et al., 1991; Thummel, 2001). In our
experiments, expression of EcR target genes including Eig71Ea,
Eig71Ee, Eip74EF, Eip93F, Fbp1, ImpE2,Sgs1 and Sgs3 was strongly
reduced in dBrms1 mutants (Fig. 3A). The effect on Eip75B was
moderate. Interestingly, the expression of EcR was also decreased
to a half of control but the expression of USP had no change
(Fig. 3A). Finally, the expression of an EcR target gene Sgs3 was
directly examined in intact larvae. Sgs3-GFP reporter transgenic
strain expresses GFP in the salivary glands at the late third-instar
larval stage speciﬁcally (Biyasheva et al., 2001). In dBrms1−/Y;
Sgs3-GFP/+ hemizygous mutants, no GFP were observed in salivary
gland at this stage (Fig. 3B), indicating that dBrms1 is critical for
Sgs3 expression. These results support a model that dBrms1
functions to maintain EcR signaling for the control of develop-
mental timing.
dBrms1 genetically interact with EcR
To determine how dBrms1 might be genetically related to
EcR function, an EcR RNAi allele was used to cause defective eye
phenotype when driven by an eye-speciﬁc driver, GMR-Gal4
(Fig. 4, compare A with B–D). Under this condition, majority of
the ﬂies exhibited slight to moderate defective eye phenotype
(Fig. 4, B–E). In a dBrms1 heterozygous background, however, the
defective eye phenotype was strongly enhanced with most of ﬂies
exhibiting moderate to severe eye defects (Fig. 4E). This genetic
evidence supports a model that dBrms1 acts to facilitate EcR
function during normal development.Discussion
Brms1 genes are evolutionarily conserved in vertebrate and
invertebrate animals (Fig. S1). While previous work has revealed a
role of human BRMS1 in inhibiting metastasis of carcinoma cells
through gain-of-function studies, the function of Brms1 genes during
animal development has not been elucidated. Using Drosophila as a
model, the developmental role of dBrms1 has been investigated
through a genetic approach in this study. We found that dBrms1 is
expressed ubiquitously throughout development (Fig. 1) and is
essential for normal development (Fig. 2). Loss-of-function mutations
in dBrms1 cause developmental delay at various stages. A striking
mutant phenotype is that dBrms1 mutant larvae can be maintained
at the third-instar stage for more than 10 days without undergoing
the transition from larval to pupal stage. The developmental delay
and failure to initiate metamorphosis are clearly associated with the
defective EcR signaling. In support of this view, we found that
expression of many EcR target genes are strongly reduced in dBrms1
mutants (Fig. 3). Moreover, genetic interaction analysis revealed that
reduction of dBrms1 gene function dominantly enhanced the loss-of-
function phenotype of EcR mutants (Fig. 4).
How does dBrms1 act to facilitate EcR signaling in regulating
developmental timing? Several models might help address this
question. In the ﬁrst model, it might involve a potential transcrip-
tion co-repressor activity of dBrms1. Human BRMS1 and BRMS1L
have been reported to act as components of SIN3-HDAC deacety-
lase complex and repress transcription (Meehan et al., 2004;
Nikolaev et al., 2004). Furthermore, another BRMS1-related
protein, SDS3, has also been found to physically associate with
SIN3-HDAC complex to repress transcription (Alland et al., 2002).
Sin3-HDAC deacetylase complex is a multi-protein assembly that
represses transcription through histone deacetylation and binding
special transcription factor (Knoepﬂer and Eisenman, 1999).
Whether dBrms1 plays the same role as other family members intranscription repression remains to be investigated. Interestingly,
some evidence suggest that the Sin3-HDAC complex and its co-
repressor, SMRTER, play a role in EcR-mediated transcriptional
repression (Tsai et al., 1999). However, loss of Sin3 function in
Drosophila does not cause developmental delay; Sin3 mutants do
not show any visible disc abnormalities although they die during
third-instar larval or pupal stages (Roch et al., 1998). Since dBrms1
functions to promote EcR target gene expression (Fig. 3), it is
unlikely that its putative transcription co-repressor activity is
directly involved in repressing expression of the EcR target genes.
In a second model, dBrms1 might actually play a positive role in
facilitating the Ecdysone/EcR/Usp complex to activate EcR target
gene expression. dBrms1 might behave as a transcription co-
activator in certain combinations with other factors in a protein
complex. This model would explain the observation that loss of
dBrms1 function reduced expression of EcR target genes. Certainly,
we cannot exclude that dBrms1 might function through other
signaling pathways that together contribute to the activation of
EcR target gene expression.
In a third model, dBrms1might be required for the biosynthesis
of ecdysone hormone, which is an essential ligand for EcR
activation. In Drosophila development, the pulses of ecdysone are
directly related to molting and metamorphosis (Riddiford, 1993;
Thummel, 2001). For instance, at the end of the third-instar larval
stage, a high titer ecdysone pulse triggers widespread changes
throughout the body to initiate metamorphosis. To test this model,
we have fed dBrms1 mutant larvae with 20-hydroxyecdysone, an
active ecdysone hormone. Although no signiﬁcant rescue was
observed, further analysis is still needed to optimize ecdysone
concentration and duration of ecdysone treatment in order to
determine how likely dBrms1 regulates EcR signaling through this
mechanism. One interesting observation is that dBrms1 promoter
activity appears to be higher in the larval ring gland than other
tissues (Fig. 2B). While ecdysone is produced in the ring gland, the
possibility that dBrms1 is required for proper development of the
ring gland will need to be investigated.
Our ﬁnding that dBrms1 is involved in regulating EcR signaling in
developing Drosophila tissues is consistent with some intriguing
observations from human cancers. A signiﬁcant correlation was
recognized between loss of BRMS1 protein expression and reduced
disease-free survival and loss of estrogen receptor and progesterone
receptor signaling in human breast cancers (Hicks et al., 2006). While
BRMS1 is normally localized in the nucleus and functions as a
transcription cofactor, cytoplasmic BRMS1 expression is associated
with increased disease-free survival and lower estrogen receptor and
progesterone receptor expression in human breast cancers (Frolova
et al., 2009). Therefore, Brms1 appears to play an evolutionarily
conserved role in regulating hormone signaling activity.
Another possible mechanism for dBrms1 to control growth rate
and developmental timing might involve action of ribosomal
protein genes. In Drosophila, mutations in many ribosomal protein
genes slowed down development and lead to poor fertility and
viability in a dominant, haplo-insufﬁcient manner (Schultz, 1929;
Marygold et al., 2007). It is possible that dBrms1 is involved for
regulating the expression of ribosomal protein genes. Further
studies are required to investigate this hypothesis.Acknowledgment
We thank Dr. Renjie Jiao for ﬂy strains, Dr. Xun Huang for his
help and the idea of feeding ﬂies with ecdysone, Dr. Xinhua Lin for
the pCaSpeR4 vector, the Bloomington Drosophila Stock Center for
ﬂy strains, and Gu Chun for participating part of work. This
research was supported by the National Natural Science Founda-
tion of China (Grant no. 30270186 and 30771058).
S. Song et al. / Developmental Biology 380 (2013) 344–350350Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2013.05.012.References
Alland, L., David, G., Shen-Li, H., Potes, J., Muhle, R., Lee, H.C., Hou Jr., H., Chen, K.,
DePinho, R.A., 2002. Identiﬁcation of mammalian Sds3 as an integral compo-
nent of the Sin3/histone deacetylase corepressor complex. Mol. Cell Biol. 22,
2743–2750.
Andres, A.J., Fletcher, J.C., Karim, F.D., Thummel, C.S., 1993. Molecular analysis of the
initiation of insect metamorphosis: a comparative study of Drosophila
ecdysteroid-regulated transcription. Dev. Biol. 160, 388–404.
Badenhorst, P., Xiao, H., Cherbas, L., Kwon, S.Y., Voas, M., Rebay, I., Cherbas, P., Wu, C.,
2005. The Drosophila nucleosome remodeling factor NURF is required for
Ecdysteroid signaling and metamorphosis. Genes Dev. 19, 2540–2545.
Bai, J., Uehara, Y., Montell, D.J., 2000. Regulation of invasive cell behavior by taiman,
a Drosophila protein related to AIB1, a steroid receptor coactivator ampliﬁed in
breast cancer. Cell 103, 1047–1058.
Bellen, H.J., Levis, R.W., Liao, G., He, Y., Carlson, J.W., Tsang, G., Evans-Holm, M.,
Hiesinger, P.R., Schulze, K.L., Rubin, G.M., Hoskins, R.A., Spradling, A.C., 2004.
The BDGP gene disruption project: single transposon insertions associated with
40% of Drosophila genes. Genetics 167, 761–781.
Biyasheva, A., Do, T.V., Lu, Y., Vaskova, M., Andres, A.J., 2001. Glue secretion in the
Drosophila salivary gland: a model for steroid-regulated exocytosis. Dev. Biol.
231, 234–251.
Brand, A.H., Perrimon, N., 1993. Targeted gene expression as a means of altering cell
fates and generating dominant phenotypes. Development 118, 401–415.
Casso, D., Ramírez-Weber, F., Kornberg, T.B., 2000. GFP-tagged balancer chromo-
somes for Drosophila melanogaster. Mech. Dev. 91, 451–454.
Cicek, M., Fukuyama, R., Welch, D.R., Sizemore, N., Casey, G., 2005. Breast cancer
metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-
kappaB activity. Cancer Res. 65, 3586–3595.
Frolova, N., Edmonds, M.D., Bodenstine, T.M., Seitz, R., Johnson, M.R., Feng, R.,
Welch, D.R., Frost, A.R., 2009. A shift from nuclear to cytoplasmic breast cancer
metastasis suppressor 1 expression is associated with highly proliferative
estrogen receptor-negative breast cancers. Tumor Biol. 30, 148–159.
Harvie, P.D., Filippova, M., Bryant, P.J., 1998. Genes expressed in the ring gland, the
major endocrine organ of Drosophila melanogaster. Genetics 149, 217–231.
Hicks, D.G., Yoder, B.J., Short, S., Tarr, S., Prescott, N., Crowe, J.P., Dawson, A.E.,
Budd, G.T., Sizemore, S., Cicek, M., Choueiri, T.K., Tubbs, R.R., Gaile, D., Nowak, N.,
Accavitti-Loper, M.A., Frost, A.R., Welch, D.R., Casey, G., 2006. Loss of breast cancer
metastasis suppressor 1 protein expression predicts reduced disease-free survival
in subsets of breast cancer patients. Clin. Cancer Res. 12, 6702–6708.
Knoepﬂer, P.S., Eisenman, R.N., 1999. Sin meets NuRD and other tails of repression.
Cell 99, 447–450.
Koelle, M.R., Talbot, W.S., Segraves, W.A., Bender, M.T., Cherbas, P., Hogness, D.S.,
1991. The Drosophila EcR gene encodes an ecdysone receptor, a new member of
the steroid receptor superfamily. Cell 67, 59–77.
Liu, Y., Smith, P.W., Jones, D.R., 2006. Breast cancer metastasis suppressor 1 func-
tions as a corepressor by enhancing histone deacetylase 1-mediated deacetyla-
tion of RelA/p65 and promoting apoptosis. Mol. Cell Biol. 26, 8683–8696.
Marygold, S.J., Roote, J., Reuter, G., Lambertsson, A., Ashburner, M., Millburn, G.H.,
Harrison, P.M., Yu, Z., Kenmochi, N., Kaufman, T.C., Leevers, S.J., Cook, K.R., 2007.
The ribosomal protein genes and Minute loci of Drosophila melanogaster.
Genome Biol. 8, R216.Meehan, W.J., Samant, R.S., Hopper, J.E., Carrozza, M.J., Shevde, L.A., Workman, J.L.,
Eckert, K.A., Verderame, M.F., Welch, D.R., 2004. Breast cancer metastasis
suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein
1 (RBP1) and the mSin3 histone deacetylase complex and represses transcrip-
tion. J. Biol. Chem. 279, 1562–1569.
Nikolaev, A.Y., Papanikolaou, N.A., Li, M., Qin, J., Gu, W., 2004. Identiﬁcation of a
novel BRMS1-homologue protein p40 as a component of the mSin3A/p33
(ING1b)/HDAC1 deacetylase complex. Biochem. Biophys. Res. Commun. 323,
1216–1222.
Rebeiz, M., Posakony, J.W., 2004. GenePalette: a universal software tool for genome
sequence visualization and analysis. Dev. Biol. 271, 431–438.
Riddiford, L.M., 1993. Hormones and Drosophila Development, in the Development
of Drosophila melanogaster. In: Bate, M., Martinez-Arias, A. (Eds.), Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 899–939.
Roch, F., Serras, F., Cifuentes, F.J., Corominas, M., Alsina, B., Lopez-Varea, A.,
Hernandez, R., Guerra, D., Cavicchi, S., Baguna, J., Garcia-Bellido, A., 1998.
Screening of larval/pupal P-element induced lethals on the second chromo-
some in Drosophila melanogaster: clonal analysis and morphology of imaginal
discs. Mol. Gen. Genet. 257, 103–112.
Samant, R.S., Clark, D.W., Fillmore, R.A., Cicek, M., Metge, B.J., Chandramouli, K.H.,
Chambers, A.F., Casey, G., Welch, D.R., Shevde, L.A., 2007. Breast cancer
metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abro-
gating NF-Kappa B activation. Mol. Cancer 6, 6.
Schultz, J., 1929. The minute reaction in the development of Drosophila melanoga-
ster. Genetics 14, 366–419.
Sedkov, Y., Cho, E., Petruk, S., Cherbas, L., Smith, S.T., Jones, R.S., Cherbas, P., Canaani, E.,
Jaynes, J.B., Mazo, A., 2003. Methylation at lysine 4 of histone H3 in ecdysone-
dependent development of Drosophila. Nature 426, 78–83.
Seraj, M.J., Samant, R.S., Verderame, M.F., Welch, D.R., 2000. Functional evidence for
a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at
chromosome 11q13. Cancer Res. 60, 2764–2769.
Shevde, L.A., Samant, R.S., Goldberg, S.F., Sikaneta, T., Alessandrini, A., Donahue, H.J.,
Mauger, D.T., Welch, D.R., 2002. Suppression of human melanoma metastasis
by the metastasis suppressor gene BRMS1. Exp. Cell Res. 273, 229–239.
Stabell, M., Eskeland, R., Bjørkmo, M., Larsson, J., Aalen, R.B., Imhof, A.,
Lambertsson, A., 2006. The Drosophila G9a gene encodes a multi-catalytic
histone methyltransferase required for normal development. Nucleic Acids Res.
34, 4609–4621.
Stabell, M., Larsson, J., Aalen, R.B., Lambertsson, A., 2007. Drosophila dSet2 functions
in H3-K36 methylation and is required for development. Biochem. Biophys. Res.
Commun. 359, 784–789.
Thomas, H.E., Stunnenberg, H.G., Stewart, A.F., 1993. Heterodimerization of the
Drosophila ecdysone receptor with retinoid X receptor and ultraspiracle. Nature
362, 471–475.
Thummel, C.S., 1996. Flies on steroids—Drosophila metamorphosis and the
mechanisms of steroid hormone action. Trends Genet. 12, 306–310.
Thummel, C.S., 2001. Molecular mechanisms of developmental timing in C. elegans
and Drosophila. Dev. Cell 1, 453–465.
Thummel, C.S., Pirrotta, V., 1992. Technical notes: new pCasper P-element vectors.
DIS 71, 150.
Tsai, C.C., Kao, H.Y., Yao, T.P., McKeown, M., Evans, R.M., 1999. SMRTER, a Drosophila
nuclear receptor coregulator, reveals that EcR-mediated repression is critical for
development. Mol. Cell 4, 175–186.
Yao, T.P., Segraves, W.A., Oro, A.E., McKeown, M., Evans, R.M., 1992. Drosophila
ultraspiracle modulates ecdysone receptor function via heterodimer formation.
Cell 71, 63–72.
Zhang, S., Lin, Q.D., Di, W., 2006. Suppression of human ovarian carcinoma
metastasis by the metastasis-suppressor gene. BRMS1. Int. J. Gynecol. Cancer
16, 522–531.
